SBIR [Phase II]: Mutant Transgenic Plant Cells as a Novel Source of Drugs

Lynn, Bert (PI)
Gerhardt, Greg (CoI)
Littleton, John (CoI)

Neuroscience

Status	Finished
Effective start/end date	1/1/17 → 7/31/19

Funding

Naprogenix

SBIR [Phase II]: Mutant Transgenic Plant Cells as a Novel Source of Drugs
Gerhardt, G. (PI), Littleton, J. (CoI) & Lynn, B. (CoI)
Naprogenix
1/1/17 → 7/31/19
Project: Research project